BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10966893)

  • 21. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone.
    Weiss EP; Shah K; Fontana L; Lambert CP; Holloszy JO; Villareal DT
    Am J Clin Nutr; 2009 May; 89(5):1459-67. PubMed ID: 19321570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
    Bruyere O; Roux C; Detilleux J; Slosman DO; Spector TD; Fardellone P; Brixen K; Devogelaer JP; Diaz-Curiel M; Albanese C; Kaufman JM; Pors-Nielsen S; Reginster JY
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3076-81. PubMed ID: 17566094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The skeletal benefits of calcium- and vitamin D3-fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study.
    Daly RM; Petrass N; Bass S; Nowson CA
    Am J Clin Nutr; 2008 Mar; 87(3):771-7. PubMed ID: 18326617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation.
    Grados F; Brazier M; Kamel S; Mathieu M; Hurtebize N; Maamer M; Garabédian M; Sebert JL; Fardellone P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5175-9. PubMed ID: 14602746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
    Panis B; Vermeer C; van Kroonenburgh MJPG; Nieman FHM; Menheere PPCA; Spaapen LJ; Rubio-Gozalbo ME
    Bone; 2006 Nov; 39(5):1123-1129. PubMed ID: 16782422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.
    Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
    Am J Med; 1995 Apr; 98(4):331-5. PubMed ID: 7709944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study.
    Lehtonen-Veromaa MK; Möttönen TT; Nuotio IO; Irjala KM; Leino AE; Viikari JS
    Am J Clin Nutr; 2002 Dec; 76(6):1446-53. PubMed ID: 12450915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dairy intakes affect bone density in the elderly.
    McCabe LD; Martin BR; McCabe GP; Johnston CC; Weaver CM; Peacock M
    Am J Clin Nutr; 2004 Oct; 80(4):1066-74. PubMed ID: 15447921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency.
    Zhu K; Bruce D; Austin N; Devine A; Ebeling PR; Prince RL
    J Bone Miner Res; 2008 Aug; 23(8):1343-8. PubMed ID: 18410225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
    Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Kuroda T; Nakamura T
    Curr Med Res Opin; 2013 Mar; 29(3):195-203. PubMed ID: 23259702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
    Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
    J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation.
    Shapses SA; Von Thun NL; Heymsfield SB; Ricci TA; Ospina M; Pierson RN; Stahl T
    J Bone Miner Res; 2001 Jul; 16(7):1329-36. PubMed ID: 11450709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
    Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.